JF
NAMS icon

Jump Financial’s NewAmsterdam Pharma NAMS Stock Holding History

Jump Financial’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.9M Buy
+144,512
New +$4.76M 0.04% 528
2025
Q1 		– Sell
-25,401
Closed -$653K – 1872
2024
Q4 		$653K Buy
+25,401
New +$540K 0.01% 955

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Jump Financial's NAMS Position: Q2 2026 in Review

Jump Financial opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 144,512 shares worth $4.9M. The stake represents 0.04% of the portfolio and ranks #528 among its holdings. This is a return to the name: Jump Financial previously reported a position in NAMS as recently as Q4 2024.

Jump Financial first reported a position in NAMS in Q4 2024 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Jump Financial held 144,512 shares of NewAmsterdam Pharma worth $4.9M as of Q2 2026.
  • NewAmsterdam Pharma was a new Jump Financial position in Q2 2026.
  • NewAmsterdam Pharma made up 0.04% of Jump Financial's portfolio in Q2 2026, its #528 holding.
  • Jump Financial first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.